FIELD: medicine, pharmaceuticals.
SUBSTANCE: present invention relates to a pharmaceutical composition comprising liposomes, said liposomes comprising an outer lipid bilayer; and an internal aqueous medium containing a weakly acidic drug with a half-life of less than 2 hours, which is treprostinil or iloprost.
EFFECT: provided is the use of the pharmaceutical composition disclosed in the present description for the treatment of pulmonary hypertension with a reduced dosing frequency.
20 cl, 19 dwg, 8 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION FOR CONTROLLED RELEASE OF WEAK ACID DRUGS AND ITS USE | 2019 |
|
RU2810790C2 |
| LIPOSOMAL COMPOSITIONS CONTAINING SLIGHTLY ACIDIC DRUGS, AND THEIR USE | 2018 |
|
RU2778886C2 |
| PHARMACEUTICAL COMPOSITION FOR TREPOSTINIL CONTROLLED RELEASE | 2019 |
|
RU2796305C2 |
| LIPOSOMAL COMPOSITIONS USED FOR DRUG DELIVERY | 2015 |
|
RU2757110C2 |
| LIPOSOMAL COMPOSITIONS APPLICABLE FOR DRUG DELIVERY | 2005 |
|
RU2574926C2 |
| PROLONGED RELEASE OF ANTI-INFECTIOUS AGENTS | 2006 |
|
RU2438655C2 |
| LIPOSOMAL COMPOSITION FOR APPLICATION IN PERITONEAL DIALYSIS | 2013 |
|
RU2609860C2 |
| LIPOSOMAL PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING IT | 2007 |
|
RU2494729C2 |
| LONG-ACTING CONTROLLED RELEASE LIPOSOMAL COMPOSITION AND METHOD FOR PRODUCING IT | 2012 |
|
RU2571077C2 |
| LIPOSOMAL COMPOSITION | 2010 |
|
RU2476216C1 |
